BlossomHill Therapeutics, Inc. (BLSM)

NASDAQ: BLSM · Real-Time Price · USD

16.35

+0.11 (0.68%)

At close: Aug 13, 2026, 4:00 PM EDT

17.24

+0.89 (5.44%)

After-hours: Aug 13, 2026, 7:39 PM EDT

BlossomHill Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-74.68	-64.02	-36.4
Net Income	-71.09	-60.56	-30.7
Earnings Per Share	-28.59	-24.83	-13.40
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	116	136.68	100.15
Total Debt	23.02	22.4	0.53
Net Cash (Debt)	92.98	114.28	99.62
Net Cash Growth	-	14.72%	-
Net Cash Per Share	37.39	46.87	43.50

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-56.89	-46.93	-31.42
Capital Expenditures	-0.68	-1.07	-0.09
Free Cash Flow	-57.56	-47.99	-31.51
Free Cash Flow Growth	-	-	-